drugset
drugset / Trial / NCT04112043

Nicotinamide Riboside as an Enhancer of Exercise Therapy in Hypertensive Older Adults (The NEET Trial)

NCT04112043 ↗

Phase 1 Completed 147 enrolled University of Florida National Institute on Aging (NIA) · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

More than 80% of older adults have hypertension, with higher prevalence of high systolic blood pressure (SBP) putting them at high risk for cardiovascular (CV) disease and death. Novel compound, nicotinamide riboside may enhance the effects of exercise therapy in hypertensive older adults.

Timeline

Start
2020-07-28
Primary completion
2023-05-26
Completion
2023-05-26

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nicotinamide riboside Small molecule 1000 mg —

Indications

hypertensive disorder